Insights into ctDNA assessment to detect minimal residual disease (MRD) in localized colorectal cancer. - Labiano I; Guerrero-Setas D; Huerta AE; Mata E; Alkorta-Aranburu G; Ordoñez GR; Berraondo P; Lecumberri A; Ochoa P; Caseda I; Termini R; Agirre-Mikelarena B; et al. (Scientific reports, 2026)